Dcvc Opportunity Fund Ii Gp is an investment fund managing more than $65.9 billion ran by Zachary Bogue. There are currently 3 companies in Mr. Bogue’s portfolio. The largest investments include Rocket Lab Usa, Inc. and Recursion Pharmaceuticals, Inc., together worth $64.2 billion.
As of 7th August 2024, Dcvc Opportunity Fund Ii Gp’s top holding is 7,203,035 shares of Rocket Lab Usa, Inc. currently worth over $34.6 billion and making up 52.4% of the portfolio value.
In addition, the fund holds 3,951,141 shares of Recursion Pharmaceuticals, Inc. worth $29.6 billion.
The third-largest holding is Rigetti Computing, Inc. worth $1.71 billion.
Currently, Dcvc Opportunity Fund Ii Gp's portfolio is worth at least $65.9 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Dcvc Opportunity Fund Ii Gp office and employees reside in Palo Alto, California. According to the last 13-F report filed with the SEC, Zachary Bogue serves as the Managing Member at Dcvc Opportunity Fund Ii Gp.
The two most similar investment funds to Dcvc Opportunity Fund Ii Gp are Davide Leone & Partners Investment Co and Troluce Capital Advisors. They manage $65.9 billion and $66.1 billion respectively.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Rocket Lab Usa, Inc. |
No change
7,203,035
|
$34,574,568,000 | 52.45% |
| Recursion Pharmaceuticals, Inc. |
No change
3,951,141
|
$29,633,558,000 | 44.95% |
| Rigetti Computing, Inc. |
No change
1,599,052
|
$1,710,986,000 | 2.60% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||